Specification of dopaminergic subsets involves interplay of En1 and Pitx3
about
Neuroprotective Transcription Factors in Animal Models of Parkinson DiseaseOtx2 Requires Lmx1b to Control the Development of Mesodiencephalic Dopaminergic NeuronsProgressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's diseaseEfficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform.Embryonic development of selectively vulnerable neurons in Parkinson's disease.Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling.Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease.Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease.Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitors.Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's DiseaseDirected differentiation of postnatal hippocampal neural stem cells generates nuclear receptor related‑1 protein‑ and tyrosine hydroxylase‑expressing cellsMest/Peg1 Is Essential for the Development and Maintenance of a SNc Neuronal Subset.Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.Genetic control of midbrain dopaminergic neuron development.Establishing diversity in the dopaminergic system.Dissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesisDetailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons.Ruthenium complex Λ-WH0402 induces hepatocellular carcinoma LM6 (HCCLM6) cell death by triggering the Beclin-1-dependent autophagy pathway.Neuronal survival in the brain: neuron type-specific mechanisms.A review of the implication of hypoxanthine excess in the physiopathology of Lesch-Nyhan disease.Engrailed 1 shapes the dopaminergic and serotonergic landscape through proper isthmic organizer maintenance and function.Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets.Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool.A PBX1 transcriptional network controls dopaminergic neuron development and is impaired in Parkinson's disease.Transcriptional repression of Plxnc1 by Lmx1a and Lmx1b directs topographic dopaminergic circuit formation.Tcf12 Is Involved in Early Cell-Fate Determination and Subset Specification of Midbrain Dopamine Neurons.Transcription Factors: Potential Cell Death Markers in Parkinson's Disease.Mouse Fgf8-Cre-LacZ lineage analysis defines the territory of the postnatal mammalian isthmus.A novel floor plate boundary defined by adjacent En1 and Dbx1 microdomains distinguishes midbrain dopamine and hypothalamic neurons.
P2860
Q26765693-949A149E-2B8C-4068-93B6-198F78D71BBFQ28550104-70E5E1E0-534D-441C-B475-753140792F6FQ30833636-522DEC27-CD54-42F7-996C-D605E0935B98Q30835073-7F5CF4D2-BF90-4CE5-8E7C-B30C2E8CBB38Q33835242-F7942C0B-38A7-43E6-91F1-67047770A7BAQ34609614-3DC8AD38-8F55-4BA1-97C8-24A574091AC1Q36101048-2FAC0C17-CEB8-4195-A7BD-F7A45B04B400Q36109874-E165E5D2-C32D-49B7-8744-9AF50EADB5D3Q36248773-31BF80FC-962F-4F96-AB02-6F74138ABB06Q36250893-8ED20D83-E70B-4B6E-A3B9-BA9E762E4EC9Q37190943-40EAD0E4-26A1-4768-91E7-76523107559AQ37583989-BB541EEB-B8A3-47D1-93D2-041A05E18DACQ38234170-A93E265D-807E-4F72-AFB1-D30912EED773Q38309820-0E8BC4AC-9A44-43F5-8AC6-43A3492CA2B0Q38598047-0671FFC6-0D4E-4B20-8CBC-1EB72C09F2DEQ38605280-6A63FB4A-0EA5-4F9C-A713-A71A0080A2B2Q38752574-FFD9B543-5C83-4122-BEDC-5520E35B3594Q38894897-791DB32E-8EE4-40B9-AA5E-56353F5082F9Q38933629-396C00BB-C0C2-4B15-9CA5-F2E38CD92190Q39025701-ACFA34D5-F502-43EA-8191-9CD2DF7C1025Q39605796-B0E362BF-133E-4903-8448-A3476F7A1215Q41050801-735E8CF1-D776-4334-83E5-C250D6EB2CFEQ41363585-648CE218-9D98-4B5F-A977-64823A950B2AQ41730772-8EDF4B0D-C2E1-4736-977E-85B975787FEBQ42378846-76A60880-C9F2-4069-BB06-0A9E15977593Q46430873-9407A2F1-CC39-4F24-BE4B-58A7363B0593Q47974836-D979BF93-9263-4388-9FFD-9A43B19E7E4BQ48136803-09DE6550-3623-42AD-9790-AD9DC693820EQ48265173-0DD1EABD-BE30-46AB-91B8-DDB390A39D07
P2860
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
description
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2013
@ast
im August 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2013/08/01)
@sk
vědecký článek publikovaný v roce 2013
@cs
wetenschappelijk artikel (gepubliceerd op 2013/08/01)
@nl
наукова стаття, опублікована в серпні 2013
@uk
مقالة علمية (نشرت في أغسطس 2013)
@ar
name
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@ast
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@en
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@nl
type
label
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@ast
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@en
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@nl
prefLabel
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@ast
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@en
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@nl
P2093
P921
P3181
P356
P1433
P1476
Specification of dopaminergic subsets involves interplay of En1 and Pitx3
@en
P2093
Annemarie J. A. van der Linden
Frank C. P. Holstege
Jamie L. Lim
Jesse V. Veenvliet
Lars von Oerthel
Maria T. M. Alves Dos Santos
Marian J. A. Groot Koerkamp
Marten P. Smidt
Willemieke M. Kouwenhoven
P304
P3181
P356
10.1242/DEV.094565
P407
P577
2013-08-01T00:00:00Z